Lotus Eye Hospital and Institute Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹89.92
- Today's High:
- ₹89.92
- Open Price:
- ₹89.92
- 52W Low:
- ₹56.3
- 52W High:
- ₹105.45
- Prev. Close:
- ₹91.75
- Volume:
- 18
Company Statistics
- Market Cap.:
- ₹562.54 million
- Book Value:
- Revenue TTM:
- ₹0
- Operating Margin TTM:
- 0%
- Gross Profit TTM:
- ₹0
- Profit Margin:
- 0%
- Return on Assets TTM:
- 0%
- Return on Equity TTM:
- 0%
Company Profile
Lotus Eye Hospital and Institute Limited had its IPO on under the ticker symbol 532998.
The company operates in the Other sector and Other industry. Lotus Eye Hospital and Institute Limited has a staff strength of 0 employees.
Stock update
Shares of Lotus Eye Hospital and Institute Limited opened at ₹89.92 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹89.92 - ₹89.92, and closed at ₹89.92.
This is a -1.99% slip from the previous day's closing price.
A total volume of 18 shares were traded at the close of the day’s session.
In the last one week, shares of Lotus Eye Hospital and Institute Limited have increased by +1.49%.
Lotus Eye Hospital and Institute Limited's Key Ratios
Lotus Eye Hospital and Institute Limited has a market cap of ₹562.54 million, indicating a price to book ratio of 0 and a price to sales ratio of 0.
In the last 12-months Lotus Eye Hospital and Institute Limited’s revenue was ₹0 with a gross profit of ₹0 and an EBITDA of ₹0. The EBITDA ratio measures Lotus Eye Hospital and Institute Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Lotus Eye Hospital and Institute Limited’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.
In Q0.33333333333333, Lotus Eye Hospital and Institute Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.
Lotus Eye Hospital and Institute Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 0
- PEG
Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Lotus Eye Hospital and Institute Limited’s profitability.
Lotus Eye Hospital and Institute Limited stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 0.
Lotus Eye Hospital and Institute Limited stock pays annual dividends of ₹ per share, indicating a yield of None and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹631.88 million
- Total Liabilities
- ₹51.92 million
- Operating Cash Flow
- ₹-21944000.00
- Capital Expenditure
- ₹30.97 million
- Dividend Payout Ratio
- 0%
Lotus Eye Hospital and Institute Limited ended 2024 with ₹631.88 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹631.88 million while shareholder equity stood at ₹575.79 million.
Lotus Eye Hospital and Institute Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹51.92 million in other current liabilities, 207963000.00 in common stock, ₹367.83 million in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹48.11 million and cash and short-term investments were ₹84.14 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Lotus Eye Hospital and Institute Limited’s total current assets stands at ₹147.10 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹11.72 million compared to accounts payable of ₹0 and inventory worth ₹27.91 million.
In 2024, Lotus Eye Hospital and Institute Limited's operating cash flow was ₹-21944000.00 while its capital expenditure stood at ₹30.97 million.
Comparatively, Lotus Eye Hospital and Institute Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹89.92
- 52-Week High
- ₹105.45
- 52-Week Low
- ₹56.3
- Analyst Target Price
- ₹
Lotus Eye Hospital and Institute Limited stock is currently trading at ₹89.92 per share. It touched a 52-week high of ₹105.45 and a 52-week low of ₹105.45. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹89.38 and 200-day moving average was ₹77.36 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 0% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Lotus Eye Hospital and Institute Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Lotus Eye Hospital and Institute Limited, an eye hospital, provides eye care and related services in India. It provides services in the areas of refractive surgery, glaucoma, retina and uvea, cornea, paediatric and squint, orbit and oculoplasty, and neuro ophthalmology. The company also offers cataracts and intraocular lenses, as well as operates an eye bank. In addition, it provides ophthalmic fellowship training courses in cornea, glaucoma, retina, and anterior segments, as well as DNB teaching and training services. The company was formerly known as Lotus Eye Care Hospital Limited and changed its name to Lotus Eye Hospital and Institute Limited in April 2013. Lotus Eye Hospital and Institute Limited was incorporated in 1997 and is based in Coimbatore, India.